D.E. Shaw & Co
GRCL

D.E. Shaw & Co’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

D.E. Shaw & Co’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,356
Closed -$200K – 3940
2021
Q2 		$200K Buy
+15,356
New +$200K ﹤0.01% 3244